Prognostic significance of international prognostic index (IPI) individual risk factors in patients with diffuse large b cell lymphoma (DLBCL) treated with rituximab (R) and chop (R-CHOP) based chemotherapy

被引：0
|
作者：
Akhtar, S. [1 ]
Soudy, H. [1 ]
Darwish, A. [1 ]
Salam, M. Abdel [1 ]
Elhassan, T. [2 ]
Rehman, A. [2 ]
Bakshi, N. [1 ]
Maghfoor, I. [1 ]
机构：
[1] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Oncol Res Unit, Riyadh, Saudi Arabia
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3635
引用
收藏
页码：S847 / S847
页数：1
相关论文
共 50 条
  • [21] Absolute lymphocyte count recovery predicts superior survival and is independent of the international prognostic index in patients treated with CHOP or R-CHOP chemotherapy for diffuse large B cell lymphoma
    Porrata, LF
    Ristow, KM
    Geyer, SM
    Markovic, SN
    Persky, DO
    Colgan, JP
    White, WL
    Witzig, TE
    Inwards, DJ
    Ansell, SM
    Micallef, IN
    Johnston, PB
    Habermann, TM
    BLOOD, 2005, 106 (11) : 274A - 274A
  • [22] Prognostic Impact Of Gender In Diffuse Large B Cell Lymphoma Patients Treated With R-CHOP Therapy
    Takahashi, Hiroyuki
    Tomita, Naoto
    Kawasaki, Rika
    Hashimoto, Chizuko
    Yamazaki, Etsuko
    Taguchi, Jun
    Sakai, Rika
    Fujisawa, Shin
    Ogawa, Koji
    Ishigatsubo, Yoshiaki
    BLOOD, 2013, 122 (21)
  • [23] The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP
    Castillo, Jorge J.
    Beltran, Brady E.
    Song, Moo-Kon
    Ilic, Ivana
    Leppa, Sirpa
    Nurmi, Heidi
    Seki, Ritsuko
    Uccella, Silvia
    Li, Jun-Min
    Treaba, Diana O.
    Stachurski, Dariusz
    Butera, James N.
    LEUKEMIA RESEARCH, 2012, 36 (04) : 413 - 417
  • [24] Enhancement of the International Prognostic Index with hematologic parameters: A new prognostic model for diffuse large B-cell lymphoma treated with R-CHOP
    Chen, H.
    Zhong, Q.
    Qin, Y.
    Yang, J.
    Liu, P.
    He, X.
    Zhou, S.
    Zhang, C.
    Gui, L.
    Yang, S.
    Zhou, L.
    Shi, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S776 - S777
  • [25] Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
    Xu-Monette, Zijun Y.
    Wu, Lin
    Visco, Carlo
    Tai, Yu Chuan
    Tzankov, Alexander
    Liu, Wei-min
    Montes-Moreno, Santiago
    Dybkaer, Karen
    Chiu, April
    Orazi, Attilio
    Zu, Youli
    Bhagat, Govind
    Richards, Kristy L.
    Hsi, Eric D.
    Zhao, X. Frank
    Choi, William W. L.
    Zhao, Xiaoying
    van Krieken, J. Han
    Huang, Qin
    Huh, Jooryung
    Ai, Weiyun
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Zhou, Fan
    Kahl, Brad S.
    Winter, Jane N.
    Xu, Wei
    Li, Jianyong
    Go, Ronald S.
    Li, Yong
    Piris, Miguel A.
    Moller, Michael B.
    Miranda, Roberto N.
    Abruzzo, Lynne V.
    Medeiros, L. Jeffrey
    Young, Ken H.
    BLOOD, 2012, 120 (19) : 3986 - 3996
  • [26] Prognostic significance of PRAME expression based on immunohistochemistry for diffuse large B-cell lymphoma patients treated with R-CHOP therapy
    Kenjiro Mitsuhashi
    Akihiro Masuda
    Yan-Hua Wang
    Masayuki Shiseki
    Toshiko Motoji
    International Journal of Hematology, 2014, 100 : 88 - 95
  • [27] Comparison of the international prognostic factors index (IPI) with the absolute monocyte and lymphocyte prognostic index (AMLPI) for patients (Pts) with diffuse large b-cell lymphoma (DLBCL) receiving R-CHOP.
    Batty, Nicolas
    Ghonimi, Elham
    Feng, Lei
    Fayad, Luis
    Younes, Anas
    Rodriguez, Maria Alma
    Romaguera, Jorge Enrique
    McLaughlin, Peter
    Samaniego, Felipe
    Kwak, Larry W.
    Hagemeister, Fredrick B.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Prognostic significance of PRAME expression based on immunohistochemistry for diffuse large B-cell lymphoma patients treated with R-CHOP therapy
    Mitsuhashi, Kenjiro
    Masuda, Akihiro
    Wang, Yan-Hua
    Shiseki, Masayuki
    Motoji, Toshiko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 100 (01) : 88 - 95
  • [29] Prognostic Impact of Immunohistochemical Profile and Microvessel Density (MVD) in Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP
    Cardesa, T.
    Gutierrez-Garcia, G.
    Climent, F.
    Arenillas, L.
    Serrano, S.
    Romagosa, V.
    Gonzalez-Barca, E.
    Campo, E.
    Lopez-Guillermo, A.
    Colomo, Ll
    LABORATORY INVESTIGATION, 2009, 89 : 256A - 256A
  • [30] The prognostic significance of the number of extranodal sites in the patients with disseminated diffuse large B-cell lymphoma treated with R-CHOP
    Yoo, C.
    Sohn, B.
    Kim, J.
    Yoon, D.
    Huh, J.
    Kim, S.
    Lee, D.
    Kim, S.
    Lee, J.
    Suh, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345